Simon C. Robson

Simon C. Robson, MD, PhD is a Professor of Medicine at Harvard Medical School and a clinical specialist in Internal Medicine-Gastroenterology at Beth Israel Deaconess Medical Center (BIDMC). His research focuses on purinergic signaling, particularly the role of CD39/CD73 pathways in liver ischemia-reperfusion injury, cardiovascular disease, and immune regulation. Clinical interests include general liver disease, portal vein thrombosis, and immune-mediated disorders.

• Education: University of Cape Town (Medical), Addington Hospital (Internship), Red Cross Hospital (Residency), Groote Schuur Hospital (Residency, Fellowship), Warwick Hospital (Fellowship), King's College Hospital (Fellowship)

His work explores how ectonucleotidases like CD39 modulate inflammation and fibrosis in organs such as the liver, heart, and brain. Recent studies highlight applications in transplant rejection, sepsis, and cancer immunotherapy. Articles emphasize sexual dimorphism in disease pathogenesis and estrogen's regulatory role in microvascular injury.

Current affiliations include Harvard Medical School and BIDMC's Liver Center. No scientific awards or student advisement details were found in the provided texts.